HCPCS Codes Similar to M1256

HCPCS Codes Similar to “M1256” Code.
Prior history of known cvd

M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	M0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	Q0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg Code added date: 20220224 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
G2156 Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9298 Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke) Code added date: 20140101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
G9299 Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given) Code added date: 20140101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G9449 History of receiving blood transfusions prior to 1992 Code added date: 20150101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON
M1158 Patient had history of immunocompromising conditions prior to or during the measurement period Code added date: 20230101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1172 Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine) Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
M1257 Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1258 Cvd risk assessment performed, have a documented calculated risk score Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
G8600 Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known well Code added date: 20100101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	G8601 Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention) Code added date: 20100101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON